Results will be reviewed during an Oral Presentation on Monday June 3rd Study outcomes demonstrate potential for Adela's MRD test to inform adjuvant treatment decisions and predict and monitor for...

Anthology, the leading provider of education solutions that support the entire learner lifecycle, today announced Professor Hod Lipson of Columbia University, an eminent voice in the fields of...

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious...

4D Path ("the Company"), a company dedicated to personalizing cancer care through their advanced approach to predicting tumor response, is pleased to announce today new clinical data highlighted...

Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...